Tirzepatide Oral Tablets 500mcg (50 Count Orals)
$100.00
Tirzepatide — dual GLP-1/GIP receptor agonist in oral tablet formulation. 500mcg per tablet, 50 tablets. Oral alternative for metabolic and weight management research without subcutaneous injection. ≥98% purity, HPLC-tested.
Research & Studies
Research Use Only
For in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. Purchaser confirms they are a qualified researcher and assumes all responsibility for compliance with applicable federal, state, and local laws. This compound may be regulated as a controlled substance or prescription drug in certain jurisdictions.
In Vitro Research Protocol Reference
Research Concentration
500 mcg–2.5 mg
Frequency
Once daily
Administration
Oral
Oral tirzepatide tablet formulation. Titrate gradually. Oral bioavailability differs from subcutaneous injection. Monitor GLP-1/GIP receptor activation, glucose tolerance, and body composition.
Tirzepatide Oral Tablets 500mcg (50 Count Orals)
$100.00
Frequently Bought Together
GHK-Cu Topical Serum
$30.00
Melanotan 2 10mg Nasal Spray
$35.00
Semax 10mg Nasal Spray
$35.00